We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

58 hedge funds and large institutions have $13M invested in Korro Bio in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.41% less ownership

Funds ownership: 0.91% → 0.5% (-0.41%)

32% less funds holding

Funds holding: 85 → 58 (-27)

52% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 21

66% less capital invested

Capital invested by funds: $38.1M → $13M (-$25.1M)

71% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 34

Holders
58
Holders Change
-27
Holders Change %
-31.76%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
21
Closed
34
Calls
$555K
Puts
–
Net Calls
+$555K
Net Calls Change
+$417K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$714K
2
Renaissance Technologies
Renaissance Technologies
New York
+$450K
3
Millennium Management
Millennium Management
New York
+$276K
4
E
Ergoteles
New York
+$211K
5
Citadel Advisors
Citadel Advisors
Florida
+$166K

Top Sellers

1
N
Nuveen
North Carolina
-$4.96M
2
WA
Wasatch Advisors
Utah
-$2.22M
3
BlackRock
BlackRock
New York
-$2.11M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.91M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
51
Fidelity Investments
Massachusetts
$1K -$1.35K -20 -65%
CSB
52
City State Bank
Iowa
$1K +$1.35K +20 New
KFS
53
Kelly Financial Services
Massachusetts
$105 – – –
Jacobs Levy Equity Management
54
Jacobs Levy Equity Management
New Jersey
– -$801K -7,556 Closed
Amundi
55
Amundi
France
– -$420K -5,493 Closed
N
56
Nuveen
North Carolina
– -$4.96M -2,733 Closed
Mariner
57
Mariner
Kansas
– -$273K -2,572 Closed
Two Sigma Investments
58
Two Sigma Investments
New York
– -$234K -2,208 Closed
SDIC
59
South Dakota Investment Council
South Dakota
– -$202K -1,901 Closed
Walleye Capital
60
Walleye Capital
New York
– -$168K -1,583 Closed
Charles Schwab
61
Charles Schwab
California
– -$161K -1,515 Closed
Connor, Clark & Lunn Investment Management (CC&L)
62
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$131K -1,240 Closed
OQS
63
Occudo Quantitative Strategies
Florida
– -$110K -1,037 Closed
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
– -$86K -815 Closed
AllianceBernstein
65
AllianceBernstein
Tennessee
– -$72K -676 Closed
SSA
66
Schonfeld Strategic Advisors
New York
– -$66K -620 Closed
Allspring Global Investments
67
Allspring Global Investments
North Carolina
– -$54K -517 Closed
JF
68
Jump Financial
Illinois
– -$54K -505 Closed
AG
69
Algert Global
California
– -$52K -495 Closed
Two Sigma Advisers
70
Two Sigma Advisers
New York
– -$52K -490 Closed
CSS
71
Cubist Systematic Strategies
Connecticut
– -$50K -470 Closed
PP
72
PDT Partners
New York
– -$50K -468 Closed
MFS
73
Mirabella Financial Services
United Kingdom
– -$49K -462 Closed
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
– -$25.4K -376 -99%
Deutsche Bank
75
Deutsche Bank
Germany
– -$37K -347 Closed
1 2
3
4

KRRO Hedge Fund Activity: Q2 2022 in Review

58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2022, worth a combined $13M — down 66% from $38.1M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of KRRO and 10 opened new positions — a net loss of 24 holders — while 21 trimmed existing stakes and 10 added.

The largest buyer was Vanguard Group, adding an estimated $714K. The largest seller was Nuveen, exiting entirely with an estimated $4.96M sold.

  • 58 institutional investors held Korro Bio (KRRO) as of Q2 2022, down from 85 in Q1 2022.
  • Funds reported $13M of Korro Bio stock for Q2 2022, down 66% quarter-over-quarter.
  • 10 funds opened new Korro Bio positions in Q2 2022 and 34 closed out, a net change of -24 holders.
  • The largest Korro Bio buyer in Q2 2022 was Vanguard Group, an estimated $714K added.
  • The largest Korro Bio seller in Q2 2022 was Nuveen, an estimated $4.96M sold.

Based on aggregated 13F filings for Q2 2022.